News blog
Neurologist charged with insider trading
The phone calls began in 2007, if not earlier. After safety committee meetings regarding clinical trials of an experimental Alzheimer’s drug, neurologist and committee-chairman Sidney Gilman would ring Mathew Martoma, a hedge-fund manager for CR Intrinsic Investors, based in Stamford, Connecticut, to fill him in on the latest data
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells